Searched by
Category - cancer
| Clip | Code No. | Product | Data | ||||
|---|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Price | Availability | |
| Sequence | Location (aa) | Storage
temp. |
|||||
|
|
|||||||
|
TC-0119-4 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-BV421 |
|
||||
|
cancer | BV421 | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LPWHRLFLL | 208-216 | 4°C | |||||
|
TC-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | 4°C | |||||
|
TC-0166-2 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLAVGATK | 4°C | ||||||
|
TC-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
|
||||
|
cancer | PE | A*24:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
TS-0017-2 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | 4°C | |||||
|
TC-0105-1 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-PE |
|
||||
|
cancer | PE | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLFGVLRLK | 4°C | ||||||
|
TC-0126-1 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-PE |
|
||||
|
cancer | PE | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | |||||
|
TC-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | |||||
|
TC-5105-4 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-BV421 |
|
||||
|
cancer | BV421 | H-2Kd | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SYVKVLHHM | 4°C | ||||||
|
TS-M072-2 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | |||||
|
TS-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| FLWGPRALV | 271-279 | 4°C | |||||
|
TC-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
|
||||
|
cancer | BV421 | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLAVGATK | 4°C | ||||||
|
TS-M082-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | |||||
|
TC-0108-2 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RISTFKNWPK | 4°C | ||||||
|
TC-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | |||||
|
TS-M070-2 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | 4°C | |||||
|
TC-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
||||
|
cancer | APC | A*03:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLFGVLRLK | 4°C | ||||||
|
TC-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | |||||
|
TS-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | 4°C | |||||
|
TC-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | ||||||
|
TC-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | |||||
|
TC-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | 4°C | |||||
|
TC-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | |||||
|
TC-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | |||||
|
TC-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | |||||
|
TC-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | |||||
|
TC-0126-2 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-APC |
|
||||
|
cancer | APC | A*01:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | |||||
|
TC-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | |||||
|
TC-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | |||||
|
TS-M115-4 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ILAKFLHWL | 4°C | ||||||
|
TS-M120-4 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLTPKKLQCV | 141-150 | 4°C | |||||
|
TS-0016-4 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RLLQETELV | 689-697 | 4°C | |||||
|
TS-0017-1 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | 4°C | |||||
|
TC-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | |
| SLLFLLFSL | 4°C | ||||||
|
TC-0119-2 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-APC |
|
||||
|
cancer | APC | B*07:02 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LPWHRLFLL | 208-216 | 4°C | |||||
|
TC-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | |||||
|
TC-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | |||||
|
TC-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | |||||
|
TC-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | |||||
|
TC-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | |||||
|
TC-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLEPGPVTV | 4°C | ||||||
|
TC-0127-1 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | |||||
|
TC-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | |||||
|
TC-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | ||||||
|
TS-M078-4 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLYDGMEHL | 4°C | ||||||
|
TS-M088-4 |
HLA-A*02:01 MUC1 Tetramer-LLLLTVLTV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLLLTVLTV | 12-20 | 4°C | |||||
|
TC-0114-1 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | ||||||
|
TS-0016-2 |
HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RLLQETELV | 689-697 | 4°C | |||||
|
TC-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | ||||||
|
TC-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | ||||||
|
TC-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | ||||||
|
TC-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | |||||
|
TC-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | ||||||
|
TC-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLEPGPVTV | 4°C | ||||||
|
TC-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLEPGPVTV | 4°C | ||||||
|
TC-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | |||||
|
TC-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | |||||
|
TC-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | |||||
|
TC-0112-2 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | ||||||
|
TC-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | |||||
|
TC-0163-4 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | |||||
|
TC-0164-2 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | |||||
|
TS-M016-4 |
HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RMFPNAPYL | 126-134 | 4°C | |||||
|
TC-0110-4 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLLFLLFSL | 4°C | ||||||
|
TC-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | |||||
|
TC-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | |||||
|
TC-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | |||||
|
TC-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | |||||
|
TS-M076-4 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLWGPRALV | 271-279 | 4°C | |||||
|
TS-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLEPGPVTA | 280-288 | 4°C | |||||
|
TC-0152-4 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | |||||
|
TC-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | |||||
|
TC-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GLLGASVLGL | 674-683 | 4°C | |||||
|
TC-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | ||||||
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | ||||||
|
TC-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | |||||
|
TC-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
||||
|
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| KLCPVQLWV | 139-147 | 4°C | |||||
|
TS-M072-4 |
HLA-A*02:01 MAGE-A2 Tetramer-YLQLVFGIEV-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YLQLVFGIEV | 157-166 | 4°C | |||||
|
TC-0110-2 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-APC |
|
||||
|
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| SLLFLLFSL | 4°C | ||||||
|
TC-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | |||||
|
TC-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | ||||||
|
TC-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
||||
|
cancer | BV421 | A*02:01 | 50 tests | ¥209,000 |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | |||||